NSCLC


Also found in: Medical.
AcronymDefinition
NSCLCNon Small Cell Lung Cancer
NSCLCNon-Small Cell Lung Carcinoma (medical condition)
NSCLCNational Senior Citizens Law Center
NSCLCNorth Shepparton Community & Learning Centre (Australia)
NSCLCNorth Sefton City Learning Centre (Aisdale, Southport, UK)
NSCLCNapa-Solano Central Labor Council (California)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Caption: Figure 1: miR-362 is upregulated in NSCLC. (a) Real-time PCR analysis of the levels of miR-362 in human NSCLC tissues and adjacent noncancer tissues.
Tagrisso is a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with clinical activity against central nervous system (CNS) metastases, for the 1st-line treatment of adult patients with locally-advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours have EGFR mutations (exon 19 deletions or exon 21 (L858R) substitution mutations).
The companies will evaluate the potential clinical value of combining these two agents to treat NSCLC and melanoma.
A total of 188 NSCLC patients, including 118 male and 70 female patients aged 41 to 77 years from the Department of Oncology, Zhejiang Provincial People's Hospital, China, between May 2013 and September 2014, were enrolled in our prospective cohort study.
To find novel NSCLC mutations, a research team led by Rebecca S.
With the cobas EGFR Mutation Test v2, the presence of specific NSCLC mutations (exon 19 deletion or exon 21 [L858R] substitution mutations) detected in patients' blood samples aids in selecting those patients who may benefit from treatment with Tarceva.
While no targeted agents have been approved for patients with early-stage NSCLC, at many institutions, molecular testing is performed for all NSCLCs at the time of initial diagnosis, irrespective of stage.
The NSCLC market will be valued at $10.9 billion in 2021, growing from $6.1 billion in 2014 at a CAGR of 8.5% -
Methods: A total of 92 patients diagnosed with NSCLC after surgery were enrolled, and they were treated with DP (DP group) and GP (GP group).
However, the expression of miR-222 in NSCLC and its prognostic values still remain unclear.
In three separate studies, researchers from China Academy of Chinese Medical Science in Beijing analysed the health benefits of Chinese herbs on patients with NSCLC, IPF, and seasonal influenza.
Cancer-related inflammation promotes NSCLC progression and metastasis.